Clinical Trial Update: A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD). [Phase 4]

View source ↗

Summary

This document reports an ongoing Phase 4 clinical trial evaluating Dyanavel XR for co-occurring fatigue symptoms in adults with ADHD; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Dyanavel XR (amphetamine (extended-release))

Snippet

Sponsor: Rochester Center for Behavioral Medicine | Conditions: Fatigue, Attention Deficit Hyperactivity Disorder | Phase 4 | Status: RECRUITING